Evaluation of inappropriate prescribing to the hospitalized elderly patients in Al Shifa hospital, Gaza, Palestine


  • Lina K. Massoud Department of Pharmacology, Faculty of Pharmacy, Al-Azhar University, Gaza, Palestine
  • Hala Z. Al Agha Department of Pharmacology, Faculty of Pharmacy, Al-Azhar University, Gaza, Palestine
  • Mahmoud H. Taleb Department of Pharmacology, Faculty of Pharmacy, Al-Azhar University, Gaza, Palestine




Beers' criteria, Contraindications, Drug-drug interactions, Elderly, Hospital, Inappropriate prescribing


Background: The current study aimed to assess the prevalence of inappropriate prescribing (IP) for hospitalized elderly patients at Al Shifa Hospital, Gaza, Palestine.

Methods: This study was a retrospective cross-sectional study. A total of 2385 prescribed drugs for 380 elderly inpatients in internal, cardiology, and respiratory departments were screened for IP. Four criteria were used to detect IP using chart review method; Drug-drug interactions (DDIs), drug contra-indications (CI), duplication of therapy and Beers' criteria 2012.

Results: The results showed that 44.2% of patients had at least one IP. Around 33.2% of the patients had DDIs, 19.2% had IP according to Beers' criteria and 1.1% had drug CI. There was no duplication of therapy. A total of 323 IP instances were detected. Of them, 74% for DDIs and 24.8% for Beers' criteria. The prevalence of overall IP was significantly influenced by age (p-value=0.024), polypharmacy (p-value<0.001), degree of morbidity (p-value<0.001), and departments (p-value=0.018). The prevalence of DDIs was influenced by polypharmacy (p-value<0.001), degree of morbidity (p-value=0.001), and departments (p-value=0.005). Finally, the prevalence of IP according to Beers' criteria was significantly influenced by departments with the highest in the cardiology department (29.7%) (P-value=0.007).

Conclusions: Although the overall IP was common, it was not far higher than that reported worldwide. The majority of IP was DDIs. Age, polypharmacy, degree of morbidity and departments influenced the occurrence of IP.


Simonson W, Feinberg JL. Medication-related problems in the elderly: Defining the issues and identifying solutions. Drug Aging. 2005;22:559-69.

Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, et al. Appropriate prescribing in elderly people: How well can it be measured and optimised? Lancet. 2007;370(9582):173-84.

Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sens S, Kaboli PJ. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54(10):1516-23.

Turnheim K. When drug therapy gets old: Pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol. 2003;38:843-53.

Gallagher P, Barry P, O'Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32(2):113-21.

American Geriatric Society. American Geriatric Society updated Beers' criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616-31.

Saab YB, Hachem A, Sinno S, El-Moalem H. Inappropriate medication use in elderly Lebanese outpatients, prevalence and risk factors. Drug Aging. 2006;23(9):743-75.

Simon SR, Chan KA, Soumerai SB, Wagner AK, Andrade SE, Feldstein AC, et al. Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc. 2005;53(2):227-32.

Vlahović-Palcevski V, Bergman U. Quality of prescribing for the elderly in Croatia-computerized pharmacy data can be used to screen for potentially inappropriate prescribing. Eur J Clin Pharmacol. 2004;60(3):217-20.

Ruggiero C, Lattanzio F, Aquila GD, Gasperini B, Cherubini A. Inappropriate drug prescriptions among older nursing home residents. Drugs Aging. 2009;26(suppl. 1):15-30.

Rancourt C, Moisan J, Baillargeon L, Verreault R, Laurin D, Gregoire JP. Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr. 2004;15(4):1-9.

Liu CL, Peng LN, Chen YT, Lin MH, Liu LK, Chen LK. Potentially inappropriate prescribing for elderly medical inpatients in Taiwan: A hospital based study. Arch. Gerontol. Geriatr. 2012;55(1):148-51.

Rothberg MB, Pekow PS, Liu F, KorcGrodzicki B, Brennan MJ, Bellantonio S, et al. Potentially inappropriate medication use in hospitalized elders. J Hosp Med. 2008;3(2):91-102.

Friedman SM, Mendelson DA, Bingham KW, Mc Cann RM. Hazards of hospitalization: Residence prior to admission predicts outcomes. Gerontologist. 2008;48(4):537-41.

Coleman EA, Smith JD, Raha D, Min SJ. Post hospital medication discrepancies: Prevalence and contributing factors. Arch Intern Med. 2005;165(16):1842-7.

Taleb MH, Abed A, Dahoudi A, Najim A, Ahmed A. Polypharmacy in Primary Care Practices among Chronic Elderly Patients in Gaza Strip. Pharmacology & Pharmacy. 2014;5:291-7.

American Society of Health System Pharmacists. AHFS drug information, 2009. Available at http://www.medscape.com/pharmacists. Accessed August, 2012.

Royal Pharmaceutical Society. British National Formulary 63. London: Pharmaceutical Press; 2012.

Stockley IH. Stockley's Drug Interactions. 7th ed. London: The Pharmaceutical Press; 2005.

Hanlon JT, Artz MB, Pieper CF, Lindblad CI, Sloane RJ, Ruby CM, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother. 2004;38(1):9-14.

Rahmawati F, Hidayyati N, Rochman W, Sulaiman S. Potentially of drug-drug interactions in hospitalized geriatric patients in a private hospital, Yogyakdarta, Indonesia. Asian Journal of Pharmaceutical and Clinical Research. 2010;3(3):191-4.

Rosas-Carrasco O, García-Peña C, Sánchez-García S, Vargas-Alarcón G, Gutiérrez-Robledo LM, Juárez-Cedillo T. The relationship between potential drug-drug interactions and mortality rate of elderly hospitalized patients. Rev Invest Clin. 2011;63(6):564-73.

Antoniou T, Gomes T, Mamdani MM, Juurlink DN. Ciprofloxacin-induced theophylline toxicity: A population-based study. Eur J Clin Pharmacol. 2011;67(5):521-6.

Allen MJ, Mclean-Versey P. Interaction between clopidogrel and proton pump inhibitors. CMAJ. 2009;180(12):1228-9.

Lin SL, Chang HM, Liu CP, Chou LP, Chan JW. Clinical evidence of interaction between clopidogrel and proton pump inhibitors. World J Cardiol. 2011;3(5):153-64.

Taha AS, McCloskey C, Prasad R, Bezlyak V. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. Lancet. 2009;374:119-25.

Momin TG, Pandya RN, Rana DA, Patel VJ. Use of potentially inappropriate medications in hospitalized elderly at a teaching hospital: A comparison between Beers 2003 and 2012 criteria. Indian J Pharmacol. 2013;45(6):603-7.

Lindblad CI, Artz MB, Pieper CF, Sloane RJ, Hajjar ER, Ruby CM, et al. Potential drug-disease interactions in frail, hospitalized elderly veterans. Ann Pharmacother. 2005;39(3):412-7.

Chua D, Lo A, Lo C. Spironolactone use in heart failure patients with end-stage renal disease on hemodialysis: Is it safe? Clin Cardiol. 2010;33(10),604-8.

Cahir C, Faheg T, Teeling M, Teljeur C, Feeling J, Bennett K. Potentially inappropriate prescribing and cost outcomes for older people: A national population study. Br J Clin Pharmacol. 2010;69(5):543-52.




How to Cite

Massoud, L. K., Al Agha, H. Z., & Taleb, M. H. (2016). Evaluation of inappropriate prescribing to the hospitalized elderly patients in Al Shifa hospital, Gaza, Palestine. International Journal of Basic & Clinical Pharmacology, 5(6), 2376–2383. https://doi.org/10.18203/2319-2003.ijbcp20164091



Original Research Articles